Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Italy / NCT04392908
Active, not recruiting Observational

Communication Memory of Cancer Diagnosis Within the Pediatric Triangle

NCT04392908 · tracked via the Priya Life Science Italy tracker
Sponsor
Meyer Children's Hospital IRCCS
Phase
Observational
Started
2019-09-01
Last updated
2025-09-26

Condition(s) studied

Memory

Investigational drug(s) / intervention(s)

Communication memory

Communication memory: All groups will undergo audio-recorder interviews. Only adults will complete a self-report questionnaire on phenomenological aspects of autobiographical memories.

Study summary

Present project aims to investigate memories related to a cancer communication diagnosis in pediatric oncology. It evaluates possible common elements and specificity between family and healthcare staff.

Eligibility

Sex
ALL
Min age
12 Years
Max age
—
Healthy volunteers
No
Inclusion criteria for pediatric patients: * age from 12 to 17 with cancer diagnosis only taken by Meyer Children's Hospital prior consent. * Italian speaking Exclusion criteria for pediatric patients: * under 12 years old and above 17; * followed by other hospital; * cognitive disability Inclusion criteria for parents: \- Italian speaking and signature informed consent. Exclusion criteria for parents: \- cognitive disability

Primary outcome measure(s)

  • Phenomenological characteristics of autobiographical memory — One day after diagnosis
    Self report questionnaire "Assessment of the Phenomenology of Autobiographical Memory - APAM"
  • Emotional characteristics of autobiographical memory — One day after diagnosis
    linguistic analysis by Linguistic Inquiry Word Count - LIWC; cluster analysis by T-Lab; Content analysis; coherence and narrative structure by High Point Anaysis.

Trial sites (1)

FacilityCityRegionStatus
Meyer Children's Hospital Florence Firenze

More Meyer Children's Hospital IRCCS trials in Italy

Psychotropic-Drug-induced QT Prolongation and ECG Monitoring in the Pediatric Population Recruiting
Multicenter Italian Cohort Study on Tuberculosis in Pediatric Age Recruiting
Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis Recruiting
SLIT ABS: Study on Patients With Autoimmune Podocytopathy Recruiting
Evaluation of the Effect of Nirsevimab on Hospitalizations Due to RSV Infection in Infants Under One Year of Age. Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04392908 on ClinicalTrials.gov ↗ ← All trials in Italy